Hidden Consequences of Interim Analyses & Adaptive Trial Options
Por um escritor misterioso
Descrição
Frontiers Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial - The Lancet Oncology
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Hidden Consequences of Interim Analyses & Adaptive Trial Options
The registration continuum in personality disorder studies: Theory, rationale, and template.
Application of Bayesian approaches in drug development: starting a virtuous cycle
PDF) Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Clinical Trial Design – Endpoints
Biomedical Research COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - National Academy of Medicine
Adaptive designs in clinical trials: why use them, and how to run and report them, BMC Medicine
Shining a light on an additional clinical burden: work-related digital communication survey study – COVID-19 impact on NHS staff wellbeing
Do we need to adjust for interim analyses in a Bayesian adaptive trial design?, BMC Medical Research Methodology
Frontiers Temporary Team Performance and Knowledge Hiding: Mediated by Interpersonal Mistrust
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke
de
por adulto (o preço varia de acordo com o tamanho do grupo)
